直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Patentee Denied Pre-suit Damages for Failing to Comply with Marking Requirement

July 22, 2020

Authored and Edited by Michelle G. Rice; Kara A. Specht; Elizabeth D. Ferrill

In Packet Intelligence LLC v. NetScout Sys., Inc., No. 2019-2041 (Fed. Cir. July 14, 2020), the Federal Circuit affirmed the district court’s holdings on infringement, invalidity, and willfulness, but reversed the pre-suit damages award because Packet Intelligence’s licensees did not mark their patent‑practicing products as required under 35 U.S.C. § 287. The Court reversed the award of pre-suit damages because the apparatus claims were subject to the marking requirement under § 287. The Court found that NetScout satisfied its preliminary burden of identifying an unmarked product it believed practiced the patent, but Packet Intelligence failed to meet its burden to prove the unmarked product did not practice the patent. Packet Intelligence contended that pre-suit damages could alternatively be supported by infringement of method claims. The Court rejected the argument, holding that method claims are not “directly infringed by the mere sale of an apparatus capable of performing the claimed process,” and Packet Intelligence failed to prove the claimed method was used and infringed. Packet Intelligence, the Court held, “cannot circumvent [the marking requirement under] § 287” to include sales of the accused products in its damages claim “simply by arguing that NetScout’s infringement of related method claims drove sales.”

Tags

damages, United States Court of Appeals for the Federal Circuit (CAFC), remedies

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

AI, Electronics, and Information Technology

Electrical and Computer Technology

Related Offices

Atlanta, GA

Washington, DC

Contacts

Michelle_Yongyuan_Rice
Michelle G. Rice
Associate
Washington, DC
+1 202 408 4229
Email
Kara A. Specht
Partner
Atlanta, GA
+1 404 653 6481
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP